BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

CombiChem Incorporated

CombiChem is a computational product discovery company that is applying its proprietary design technology and rapid synthesis capabilities to accelerate the discovery process for new drugs and chemical products. CombiChem believe their approach offers pharmaceutical and chemical companies the opportunity to conduct their discovery efforts in a more productive and cost-effective manner. Using CombiChem's proprietary Discovery Engine(TM) process, they focus on the generation, evolution and optimization of potential new lead candidates for their collaborative partners who will then develop, manufacture, market and sell any resulting products. CombiChem believe that their process is widely applicable to a variety of disease targets and therapeutic indications as well as to other industries such as agrochemical, industrial chemical and materials science. CombiChem have established collaborative agreements with Athena Neurosciences, Inc., a wholly owned subsidiary of Elan Corporation, plc, ICOS Corporation, ImClone Systems Incorporated, Novartis Crop Protection AG, Ono Pharmaceutical Co., Ltd., Roche Bioscience, a division of Syntex (U.S.A.) Inc., Sumitomo Pharmaceuticals Co., Ltd. and Teijin Limited. In addition, CombiChem are using their approach on internal programs to discover new lead candidates that will then be outlicensed to third parties, while retaining a larger economic interest. In December 1998, CombiChem further broadened the application of their technology by establishing a joint venture with Chirotech Technology, Ltd., a member of the Chiroscience Group of companies, to commercialize libraries of chiral compounds. The joint venture, ChiroChem Discovery Services, LLC, was established to develop and sell specifically designed chiral compound libraries.


Contact Details:
9050 Camino Santa Fe
San Diego
CA
92121
United States of America
Tel:619 530 0484
Fax:619 530 9998
Email:

Loading...

Recent Publications by CombiChem Incorporated:

Identification of ring-fused pyrazolo pyridin-2-ones as novel poly(ADP-ribose)polymerase-1 inhibitors.
A novel class of PARP-1 inhibitors was identified containing a...
21st August, 2008
Deltagen Research Laboratories (Former CombiChem, Inc.), 4570 Executive Bioorg Med Chem Lett. 2008 Sep 15;18(18):5126-9. Epub 2008 Jul 27.
DOI Direct Link
A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli.
This study aimed at developing a whole cell based high throughput...
25th June, 2008
CombiChem Bio Resource Center, National Chemical Laboratory, Dr. Homi J Microbiol Methods. 2008 Apr;73(1):62-8. Epub 2008 Feb 11.
DOI Direct Link
Development of a simple assay protocol for high-throughput screening of Mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors.
Mycobacterium tuberculosis glutamine synthetase (GS) is an essential...
19th June, 2008
Combichem Bioresource Center, National Chemical Laboratory, Dr. Homi J Biomol Screen. 2005 Oct;10(7):725-9. Epub 2005 Aug 29.
DOI Direct Link
Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series.
SAR studies were conducted around lead compound 1 using high-throughput...
10th June, 2008
Deltagen Research Laboratories (Former CombiChem, Inc.), 4570 Executive Bioorg Med Chem Lett. 2008 Mar 15;18(6):1869-73. Epub 2008 Feb 10.
DOI Direct Link
Synthesis of novel N-rich polycyclic skeletons based on azoles and pyridines.
An efficient method for the synthesis of new polycyclic skeletons:...
14th November, 2007
Combichem Unit, Medicinal Chemistry & Process Division, Central Drug J Comb Chem. 2007 Sep-Oct;9(5):783-92. Epub 2007 Jun 15.
DOI Direct Link

View more CombiChem Incorporated research publications.

CombiChem Incorporated Patents:

US Patent No.Title
6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
6210571 Automated on-line evaporating light scattering detection to quantify isolated fluid sample compounds in microtiter plate format
6194612 Template for solution phase synthesis of combination libraries
6107313 Dopamine receptor antagonists
6077438 Automated on-line evaporation light scattering detection to quantify isolated fluid sample compounds in microtiter plate format

View more CombiChem Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 188 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: teijin Deltagen | combichem | combichem a | combichem bioresource center | chirotech | .

Search for more companies in San Diego

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for CombiChem Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.